Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aortic Stenosis and PhosphodiEsterase Type 5 iNhibition (ASPEN): A Pilot Study

NCT01275339 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT01275339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01275339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aortic Stenosis and PhosphodiEsterase Type 5 iNhibition (ASPEN): A Pilot Study
Lead sponsor
Washington University School of Medicine
Phase
Phase 4
Overall status
Terminated
Start date
December 31, 2012
Completion date
April 14, 2017
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, lv remodeling, hypertrophy